Published in Malaria Weekly, November 28th, 2005
Study 1: A study from England has reported on interactions of mefloquine with multidrug resistance proteins (MRPs) present in human red cell membranes.
"Human erythrocyte membranes express the multidrug resistance-associated proteins, MRPI, MRP4 and 5, that collectively can efflux oxidized glutathione, glutathione conjugates and cyclic nucleotides. It is already known that the quinoline derivative, MK-571, is a potent inhibitor of MRP-mediated transport.
"We here examine whether the quinoline-based antimalarial drugs, amodiaquine,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Malaria Weekly
Source: Malaria Weekly (2005-11-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.